摘要
支原体肺炎(mycoplasma pneumoniae pneumonia,MPP)是儿童社区获得性肺炎的重要组成部分,近年来MPP发病率呈逐年增高趋势,其中部分患儿病情进展快,或出现严重并发症,逐步发展为难治性支原体肺炎(refractory mycoplasma pneumoniae pneumonia,RMPP)。目前认为支原体感染导致的过度炎症反应是RMPP发病的重要原因之一,因此测定相应体液标志物有可能成为早期预测RMPP发生的重要方法。
Mycoplasma pneumoniae pneumonia is critical part of Community-acquired pneumonia,in recent decades,the incidence of mycoplasma pneumoniae pneumonia has been increased,some of them deteriorated rapidly or had serious complications,gradually become refractory mycoplasma pneumoniae pneumonia.Currently,the excessive inflammatory reaction caused by mycoplasma infection is one of the important reason for refractory mycoplasma pneumoniae pneumonia.Therefore,the determination of corresponding biomarkers could be a feasible method for early prediction of RMMP occurrence.
作者
韩姝奕
杨淑兰
胡景伟
HAN Shu-yi;YANG Shu-lan;HU Jing-wei(Graduate School of Inner Mongolia Medical University,Huhhot 010050 China;Department of Pediatrics,The Inner Mongolia Chifeng Hospital,Chifeng 024000 China)
出处
《内蒙古医学杂志》
2019年第1期38-40,共3页
Inner Mongolia Medical Journal
基金
内蒙古自治区卫生计生委医疗卫生计生科研计划项目(201703231)
内蒙古医科大学科技百万工程(联合)项目计划[YKD2016KJBW(LH)034]
关键词
儿童
难治性支原体肺炎
预测
children
refractory mycoplasma pneumoniae pneumonia
biomarkers
predictors
作者简介
韩姝奕(1993-),女,蒙古族,内蒙古赤峰市人。在读硕士研究生。;通讯作者:杨淑兰,E-mail:qqyangshulan@163.com。
